Sun Yat-sen University
Clinical trials sponsored by Sun Yat-sen University, explained in plain language.
-
New drug combo for cervical cancer shows early promise, but trial halted
Disease control TerminatedThis early-phase trial tested a combination of two drugs—toripalimab (an immunotherapy) and chidamide (a targeted therapy)—in women with advanced cervical cancer that had spread or returned. Only 5 participants were enrolled before the study was terminated. The goal was to see if…
Phase: PHASE1, PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 23, 2026 19:47 UTC
-
Experimental cell therapy shows promise in rare sarcoma trial
Disease control TerminatedThis study tested a new cell therapy called TAEST16001 in 8 adults with advanced soft tissue sarcoma who had specific genetic markers (HLA-A*02:01 and NY-ESO-1). The goal was to see if the treatment could shrink tumors. The trial was stopped early, so results are limited.
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 22, 2026 12:07 UTC
-
Lung cancer drug trial halted early: what toripalimab Couldn't prove
Disease control TerminatedThis phase II trial tested whether the immunotherapy drug toripalimab could help patients with limited-stage small cell lung cancer stay cancer-free longer after standard chemoradiotherapy. The study planned to enroll 170 adults aged 18-75 who had not progressed after treatment. …
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 22, 2026 11:57 UTC